Actively Recruiting

Phase 2
Age: 0 - 2Years
All Genders
NCT07047144

A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy

Led by Scholar Rock, Inc. · Updated on 2026-05-01

52

Participants Needed

25

Research Sites

180 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This double-blind, Phase 2, multiple-dose study will be conducted to evaluate the PK/PD, efficacy, safety, and tolerability of apitegromab in subjects \<2 years old with 5q autosomal recessive SMA who have delayed motor milestones for their age attributed to SMA at the discretion of the Investigator or a Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP-INTEND) score \<55.

CONDITIONS

Official Title

A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy

Who Can Participate

Age: 0 - 2Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Younger than 2 years old at the time of informed consent
  • Born at gestational age of 35 weeks or more with birth weight of at least 2.0 kg
  • Confirmed diagnosis of 5q autosomal recessive spinal muscular atrophy (SMA)
  • Confirmed presence of SMN2 gene copy or copies
  • Currently treated or previously treated with approved SMN1 or SMN2-targeted therapies (e.g., onasemnogene abeparvovec, nusinersen, risdiplam)
  • Body weight for age not less than 1st percentile based on WHO Child Growth Standards at screening
  • Delayed motor milestones for age due to SMA or CHOP-INTEND score less than 55
Not Eligible

You will not qualify if you...

  • Unstable nutritional status or medical need for gastric feeding tube with most feeds administered this way
  • Major orthopedic problems such as severe scoliosis, severe contractures, or recent/anticipated spine or hip surgery that limit motor function evaluation
  • Other physical limitations (e.g., requiring a cast for contractures) preventing motor function assessments during the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 25 locations

1

Phoenix Children's Hospital

Phoenix, Arizona, United States, 85016

Actively Recruiting

2

Children's Hospital of Orange County (CHOC)

Orange, California, United States, 92868

Actively Recruiting

3

Stanford Neuroscience Health Center (SNHC)

Palo Alto, California, United States, 94304

Actively Recruiting

4

Children's Hospital Colorado

Aurora, Colorado, United States, 80045

Actively Recruiting

5

Children's Healthcare of Atlanta

Atlanta, Georgia, United States, 30329

Actively Recruiting

6

University of Iowa

Iowa City, Iowa, United States, 52242

Actively Recruiting

7

Helen DeVos Children's Hospital at Spectrum Health

Grand Rapids, Michigan, United States, 49503

Actively Recruiting

8

Atrium Health Wake Forest Baptist

Winston-Salem, North Carolina, United States, 27157

Actively Recruiting

9

The Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

10

Le Bonheur Children's Hospital

Memphis, Tennessee, United States, 38103

Not Yet Recruiting

11

University of Texas Southwestern Medical Center

Dallas, Texas, United States, 75207

Actively Recruiting

12

Neurology Rare Disease Center

Flower Mound, Texas, United States, 75028

Actively Recruiting

13

Cook Children's Medical Center

Fort Worth, Texas, United States, 76104

Actively Recruiting

14

Texas Children's Hospital (TCH)-Clinical Care Center (CCC)

Houston, Texas, United States, 77030

Actively Recruiting

15

UZ Gent

Ghent, East-Flanders, Belgium, 9000

Actively Recruiting

16

UZ Leuven - Campus Gasthuisberg

Leuven, Belgium, 3000

Actively Recruiting

17

CHR Citadelle

Liège, Belgium, 4000

Actively Recruiting

18

Hopital Trousseau - I-Motion

Paris, France, 75012

Actively Recruiting

19

Fondazione I.R.C.C.S. - Istituto Neurologico Carlo Besta

Milan, Italy, 20133

Actively Recruiting

20

Centro Clinico NeMO Milano - Fondazione Serena Onlus

Milan, Italy, 20162

Actively Recruiting

21

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Rome, Italy, 00168

Actively Recruiting

22

Universitair Medisch Centrum Utrecht

Utrecht, Netherlands, 3584 CX

Actively Recruiting

23

Hospital Sant Joan de Déu Barcelona

Barcelona, Spain, 08950

Actively Recruiting

24

Hospital Universitari i Politecnico La Fecnic La Fe

Valencia, Spain, 46026

Actively Recruiting

25

Leeds General Infirmary Children's Research Department

Leeds, West Yorkshire, United Kingdom, LS1 3EX

Actively Recruiting

Loading map...

Research Team

S

Scholar Rock

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy | DecenTrialz